Sodium Oxybate: Another Threat to Fibromyalgia Sufferers

Sodium Oxybate is now in phase III trial. A result on fibromyalgia over 14 weeks (seems to be the magic number for a life long disease!) has just been presented. About 50% of patients had a decrease of 30% or more of their pain.

Is That All?

Will such a small result justify to expose so many patients to GHB. Because that's what sodium oxybate is! A recreational drug that expose its users to addiction, withdrawal symptoms, seizures etc... The list is really long and you can have a look at it on

http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=meds&log$=drug_bottom_one&part=a605032

Here is a dangerous drug whose mode of action is on the NMDA receptors (and their trigger, the AMPA receptors). We already had ketamine (analogue to LSD or big K for the junkies) that is acting on the NMDA receptors. Now they add this one!
Magnesium is not dangerous and acts on the NMDA receptors. But for sure, it does not represent a multi-billions market!

Let's hope this one does not pass the board. We don't need to add more misery to fibromyalgia.